EE200300430A - Tiolutiindioksiidi ja selle derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud kesknärvisüsteemi häirete raviks, ühendite saamine Nocardiopsis mikroorganismi osavõtul ning selle mikroorganismi tüvi ST 100692 (DSM 13834) - Google Patents
Tiolutiindioksiidi ja selle derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud kesknärvisüsteemi häirete raviks, ühendite saamine Nocardiopsis mikroorganismi osavõtul ning selle mikroorganismi tüvi ST 100692 (DSM 13834)Info
- Publication number
- EE200300430A EE200300430A EEP200300430A EEP200300430A EE200300430A EE 200300430 A EE200300430 A EE 200300430A EE P200300430 A EEP200300430 A EE P200300430A EE P200300430 A EEP200300430 A EE P200300430A EE 200300430 A EE200300430 A EE 200300430A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- microorganism
- dsm
- medicament
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01105959A EP1238668A1 (en) | 2001-03-09 | 2001-03-09 | Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of CNS disorders and a process for the preparation thereof |
| PCT/EP2002/001915 WO2002072089A2 (en) | 2001-03-09 | 2002-02-23 | Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200300430A true EE200300430A (et) | 2003-12-15 |
Family
ID=8176735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200300430A EE200300430A (et) | 2001-03-09 | 2002-02-23 | Tiolutiindioksiidi ja selle derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud kesknärvisüsteemi häirete raviks, ühendite saamine Nocardiopsis mikroorganismi osavõtul ning selle mikroorganismi tüvi ST 100692 (DSM 13834) |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20020193418A1 (xx) |
| EP (2) | EP1238668A1 (xx) |
| JP (1) | JP2004521927A (xx) |
| KR (1) | KR20040025902A (xx) |
| CN (1) | CN1279906C (xx) |
| AT (1) | ATE333276T1 (xx) |
| AU (1) | AU2002250997B2 (xx) |
| BG (1) | BG108161A (xx) |
| BR (1) | BR0207884A (xx) |
| CA (1) | CA2439853A1 (xx) |
| CZ (1) | CZ20032427A3 (xx) |
| DE (1) | DE60213219D1 (xx) |
| EE (1) | EE200300430A (xx) |
| HR (1) | HRP20030714A2 (xx) |
| IL (1) | IL157792A0 (xx) |
| MX (1) | MXPA03007551A (xx) |
| NO (1) | NO20033964L (xx) |
| NZ (1) | NZ528071A (xx) |
| PL (1) | PL363374A1 (xx) |
| RU (1) | RU2003129889A (xx) |
| SK (1) | SK11202003A3 (xx) |
| WO (1) | WO2002072089A2 (xx) |
| YU (1) | YU68403A (xx) |
| ZA (1) | ZA200306474B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108371661B (zh) * | 2018-01-19 | 2019-03-19 | 中国人民解放军军事科学院军事医学研究院 | 硫藤黄菌素在抑制nlrp3炎症小体活化中的应用 |
| CN113209088B (zh) * | 2021-03-11 | 2022-03-22 | 中国人民解放军军事科学院军事医学研究院 | 硫藤黄菌素在保护非酒精性脂肪性肝炎中的应用 |
| CN115261422A (zh) * | 2022-06-30 | 2022-11-01 | 塔里木大学 | 一种新物种来源硫藤黄菌素的制备方法及应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2217957A1 (en) * | 1995-04-11 | 1996-10-17 | Genhui Chen | Xenorxides with antibacterial and antimycotic properties |
| CA2212237A1 (en) * | 1997-09-05 | 1999-03-05 | John M. Webster | Novel antineoplastic agents |
-
2001
- 2001-03-09 EP EP01105959A patent/EP1238668A1/en not_active Withdrawn
-
2002
- 2002-02-23 DE DE60213219T patent/DE60213219D1/de not_active Expired - Lifetime
- 2002-02-23 NZ NZ528071A patent/NZ528071A/en unknown
- 2002-02-23 BR BR0207884-8A patent/BR0207884A/pt not_active IP Right Cessation
- 2002-02-23 CA CA002439853A patent/CA2439853A1/en not_active Abandoned
- 2002-02-23 MX MXPA03007551A patent/MXPA03007551A/es unknown
- 2002-02-23 CZ CZ20032427A patent/CZ20032427A3/cs unknown
- 2002-02-23 SK SK1120-2003A patent/SK11202003A3/sk unknown
- 2002-02-23 EE EEP200300430A patent/EE200300430A/xx unknown
- 2002-02-23 RU RU2003129889/15A patent/RU2003129889A/ru not_active Application Discontinuation
- 2002-02-23 KR KR10-2003-7011817A patent/KR20040025902A/ko not_active Application Discontinuation
- 2002-02-23 AT AT02719902T patent/ATE333276T1/de not_active IP Right Cessation
- 2002-02-23 IL IL15779202A patent/IL157792A0/xx unknown
- 2002-02-23 JP JP2002571048A patent/JP2004521927A/ja not_active Abandoned
- 2002-02-23 PL PL02363374A patent/PL363374A1/xx unknown
- 2002-02-23 CN CNB028079493A patent/CN1279906C/zh not_active Expired - Fee Related
- 2002-02-23 EP EP02719902A patent/EP1372640B1/en not_active Expired - Lifetime
- 2002-02-23 YU YU68403A patent/YU68403A/sh unknown
- 2002-02-23 WO PCT/EP2002/001915 patent/WO2002072089A2/en not_active Application Discontinuation
- 2002-02-23 AU AU2002250997A patent/AU2002250997B2/en not_active Ceased
- 2002-03-08 US US10/092,882 patent/US20020193418A1/en not_active Abandoned
-
2003
- 2003-08-20 ZA ZA200306474A patent/ZA200306474B/en unknown
- 2003-09-08 NO NO20033964A patent/NO20033964L/no unknown
- 2003-09-08 BG BG108161A patent/BG108161A/xx unknown
- 2003-09-08 HR HR20030714A patent/HRP20030714A2/xx not_active Application Discontinuation
-
2004
- 2004-10-26 US US10/973,309 patent/US20050059725A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SK11202003A3 (sk) | 2004-02-03 |
| CN1501800A (zh) | 2004-06-02 |
| KR20040025902A (ko) | 2004-03-26 |
| PL363374A1 (en) | 2004-11-15 |
| US20050059725A1 (en) | 2005-03-17 |
| YU68403A (sh) | 2006-08-17 |
| IL157792A0 (en) | 2004-03-28 |
| MXPA03007551A (es) | 2003-12-04 |
| CA2439853A1 (en) | 2002-09-19 |
| DE60213219D1 (de) | 2006-08-31 |
| NO20033964D0 (no) | 2003-09-08 |
| CZ20032427A3 (cs) | 2004-01-14 |
| EP1372640B1 (en) | 2006-07-19 |
| US20020193418A1 (en) | 2002-12-19 |
| ATE333276T1 (de) | 2006-08-15 |
| ZA200306474B (en) | 2004-04-29 |
| NZ528071A (en) | 2005-02-25 |
| BR0207884A (pt) | 2004-07-27 |
| RU2003129889A (ru) | 2005-03-10 |
| HRP20030714A2 (en) | 2005-04-30 |
| EP1372640A2 (en) | 2004-01-02 |
| AU2002250997B2 (en) | 2006-03-09 |
| WO2002072089A2 (en) | 2002-09-19 |
| WO2002072089A3 (en) | 2002-11-14 |
| CN1279906C (zh) | 2006-10-18 |
| JP2004521927A (ja) | 2004-07-22 |
| BG108161A (en) | 2004-09-30 |
| EP1238668A1 (en) | 2002-09-11 |
| NO20033964L (no) | 2003-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0015533A (pt) | Iduronidase-alfa-l recombinante, métodos para sua produção e purificação e métodos para tratamento de doenças causadas por deficiências da mesma | |
| ATE427114T1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen | |
| EP1404324A4 (en) | PROMOTERS OF GABA ANALOGS, COMPOSITIONS AND USES OF SAID PROMEDICAMENTS | |
| MXPA03010232A (es) | Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central. | |
| SG157231A1 (en) | Substituted p-diaminobenzene derivatives | |
| MY124786A (en) | Bis-arylsulfones | |
| CA2498291A1 (en) | Diazabicyclic compounds useful in the treatment of cns and other disorders | |
| ATE526981T1 (de) | Verwendung von vegf 165 und homologen zur behandlung von neurologischen störungen | |
| IL158738A0 (en) | Novel use of 2-phenyl-substituted imidazotriazinones | |
| HK1080079B (zh) | 製備2-甲基哌嗪衍生物的方法 | |
| EE200300430A (et) | Tiolutiindioksiidi ja selle derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud kesknärvisüsteemi häirete raviks, ühendite saamine Nocardiopsis mikroorganismi osavõtul ning selle mikroorganismi tüvi ST 100692 (DSM 13834) | |
| BR0001342A (pt) | Processo para a produção de l-aminoácidos por meio de fermentação usando bactérias corineformes | |
| PT1254905E (pt) | 4-(2-piridil) piperizinas possuindo actividade agonista do receptor 5ht7 | |
| MA28213A1 (fr) | Derives de bengamide, procede de production de ceux-ci et leur utilisation pour le traitement du cancer | |
| ATE402253T1 (de) | Humane adulte astrozyten, sowie deren herstellung und verwendung | |
| ATE334680T1 (de) | 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel | |
| MXPA03001272A (es) | Procedimiento para la preparacion de dinapsolina. | |
| UA74426C2 (uk) | Фенілпіперазини | |
| YU67203A (sh) | Derivati caloporosida, postupak za njihovu proizvodnju i njihova primena | |
| WO2004016604A3 (en) | Azabicyclic compounds are central nervous system active agents | |
| MXPA04001951A (es) | Coniosulfuros y sus derivados, procesos para prepararlos, y su uso como farmaceuticos. | |
| MXPA04000953A (es) | Derivados sustituidos del acido 5,6,6a,11b-tetrahidro-7-oxa-aza-benzo[c]fluoren-6-carboxilico como antagonista de nmda. | |
| BR0307199A (pt) | Derivados de drechsleranol, processo para a sua preparação e sua aplicação | |
| BR0312337A (pt) | Derivados de ácido polienocarboxìlico, processo para a sua preparação e seu emprego | |
| WO2002072527A3 (de) | 1-butansäurederivate wie z.b. carbomethoxypropionylcyanid oder leflunomidderivate und deren therapeutische anwendung |